FDA Inspection 655593 — Azurity Pharmaceuticals, Inc.

Azurity Pharmaceuticals, Inc. — FEI 3003395329

The FDA completed an inspection of Azurity Pharmaceuticals, Inc. on Mar 19, 2010 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 19, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Woburn, MA (United States)

Citations

IDCFRDescription
45421 CFR 820.40(a)Document review, approval by designated individual

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.